Kalaris Therapeutics, Inc. · NASDAQ:KLRS

Srinivas Akkaraju reported a 56.50% stake in Kalaris Therapeutics, Inc. (Schedule 13D/A)

Event Dec 22, 2025 · Filed Dec 22, 2025

Srinivas Akkaraju reported a 56.50% stake in Kalaris Therapeutics, Inc., 12,953,581 shares, with active intent on Dec 22, 2025. Filed Dec 22, 2025 (Schedule 13D/A).

Stake
56.50%
Shares
12,953,581
Intent
Active
What changed
Stake changed
Filed together
5 holders

The filing in full

HolderStakeShares
Samsara BioCapital, L.P.50.00%11,448,081
Samsara BioCapital GP, LLC50.00%11,448,081
Samsara Opportunity Fund, L.P.6.50%1,500,000
Samsara Opportunity Fund GP, LLC6.50%1,500,000
Srinivas Akkaraju56.50%12,953,581

Source

View original at SEC

Related